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The involvement of the serotonin system in the pathophysiology of schizophrenia has been
elucidated by experiments with hallucinogens. Application of a hallucinogen to humans
leads to changes in perception, cognition, emotions, and induction of psychotic-like symp-
toms that resemble symptoms of schizophrenia. In rodent studies, their acute administra-
tion affects sensorimotor gating, locomotor activity, social behavior, and cognition including
working memory, the phenotypes are considered as an animal model of schizophrenia.The
complexity and singularity of human cognition raises questions about the validity of ani-
mal models utilizing agonists of 5-HT2A receptors.The present study thus investigated the
effect of psilocin on memory acquisition, reinforced retrieval, and memory consolidation
in rats. Psilocin is a main metabolite of psilocybin acting as an agonist at 5-HT2A receptors
with a contribution of 5-HT2C and 5-HT1A receptors. First, we tested the effect of psilocin
on the acquisition of a Carousel maze, a spatial task requiring navigation using distal cues,
attention, and cognitive coordination. Psilocin significantly impaired the acquisition of the
Carousel maze at both doses (1 and 4 mg/kg).The higher dose of psilocin blocked the learn-
ing processes even in an additional session when the rats received only saline. Next, we
examined the effect of psilocin on reinforced retrieval and consolidation in the Morris water
maze (MWM). The dose of 4 mg/kg disrupted reinforced retrieval in the MWM. However,
the application of a lower dose was without any significant effect. Finally, neither the low
nor high dose of psilocin injected post-training caused a deficit in memory consolidation
in the MWM. Taken together, the psilocin dose dependently impaired the acquisition of
the Carousel maze and reinforced retrieval in MWM; however, it had no effect on memory
consolidation.
Keywords: psilocin, spatial memory, Carousel maze, Morris water maze, allocentric navigation, hallucinogenic
alkaloids, learning, memory
INTRODUCTION
Psilocybin (O-phosphoryl-4-hydroxy-N,N -dimethyltryptamine)
and its active metabolite psilocin (4-hydroxy-N,N -dimethyltrypt
amine) are the main psychoactive indolealkylamines contained
in hallucinogenic mushrooms (Hasler et al., 1997; Passie et al.,
2002; Tyls et al., 2013). They act as agonists at serotonin recep-
tors, mainly 5-HT2A/C and 5-HT1A subtypes (for a review, see
Tyls et al., 2013). Recently, affinities to other than serotonergic
receptors have also been reported (e.g., D1 and D3 receptors);
however, their role in the neurobiology of psilocin’s and psilocy-
bin’s action is disputable (Ray, 2010). Nevertheless, most of the
evidence agrees that hallucinogenic effects are mediated mainly
via agonism at postsynaptic 5-HT2A receptors with a contribution
of 5-HT2C and 5-HT1A receptors (Nichols, 2004). A secondary
role of the activated limbic dopaminergic system also seems to be
responsible for some of its effects (Vollenweider et al., 1999).
The acute effects of psilocybin in humans are character-
ized by changes in perception, cognition, emotions, and induc-
tion of psychotic-like symptoms that resemble early stages
of schizophrenia (Vollenweider et al., 1998). Psilocybin also
attenuates neurocognitive parameters in humans (e.g., disrupted
sustained attention and altered visual information processing)
and disrupts sensorimotor processing (Tyls et al., 2013), effects
that are also typically disrupted in psychotic patients (Park
and Holzman, 1992; Vollenweider et al., 1997, 1998; Geyer,
1998). Due to this phenomenological resemblance of acute
intoxication with psychosis and its long history of safe clin-
ical use (including psychiatric treatment) it is, nowadays, the
most frequently used serotonergic model of psychosis in humans
(Tyls et al., 2013). Furthermore, the therapeutic potential of
psilocin/psilocybin has been recently investigated in several psy-
chiatric disorders such as obsessive–compulsive disorder, anxiety,
and addiction (Moreno et al., 2006; Grob et al., 2011; Bogen-
schutz and Pommy, 2012; Stebelska, 2013; dos Santos, 2014).
Despite the evidence of how psilocybin changes cognitive per-
formance in humans, little is known about its effects on cognition
in animals.
To further investigate the effect of psilocin on cognition in
animals we decided to test spatial memory using two spatial par-
adigms: the Morris water maze (MWM) and the Carousel maze.
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Spatial navigation as a behavioral manifestation of knowledge of
the environment (i.e., cognitive map; Tolman, 1948) is consid-
ered as a useful and experimentally well-accessible animal analogy
of declarative memory (O’Keefe and Nadel, 1978; Eichenbaum,
2001; Morris, 2013). Testing of spatial navigation requires sensi-
tive spatial paradigms, such as the MWM (Morris, 1981; Morris
et al., 1982; Stuchlik et al., 2007). This test can be used in many
configurations, allowing testing of reference and working memory
acquisition, consolidation, and retrieval. The water maze typically
requires so-called allocentric spatial memory, i.e., guidance of nav-
igation by spatial relationships of the distal visual cues located
in the experimental room. Another powerful and relatively novel
spatial paradigm is active place avoidance in a Carousel maze, pre-
viously also referred to as active allothetic place avoidance (AAPA)
(Cimadevilla et al., 2000, 2001; Stuchlik et al., 2004; Wesierska et al.,
2005). In this test, animals walking on a slowly rotating arena are
required to avoid a sector located in a stable position of the room.
It was demonstrated that rats avoiding places remember the arena-
and room-based frames of reference (Fenton et al., 1998), which
are continuously dissociated by the rotation of the arena. In its
active place avoidance version, animals must, besides allocentric
mapping, segregate spatial information into coherent representa-
tions of the room and arena frames and to select the room frame
as the only one relevant for navigation. This ability was shown to
strictly require hippocampus and termed cognitive coordination
(Wesierska et al., 2005). Importantly, this task was demonstrated to
require the presence of visual extra-arena information in the room
frame (Fajnerova et al., 2014) as well as vestibular inertial stimu-
lation caused by continuous arena rotation, which likely enhances
the attention of the rats to distal visual cues (Blahna et al., 2011).
The aim of the present study is to test the hypothesis that
psilocin attenuates acquisition of the Carousel maze (demanding
mainly cognitive coordination) and reinforced retrieval and mem-
ory consolidation in the MWM (demanding allocentric memory).
The effect of psilocin on the locomotor activity was assessed in the
Carousel maze in order to dissociate effects upon cognition and/or
motor and motivational functions.
MATERIALS AND METHODS
ANIMALS
All experimental procedures complied with the Animal Protec-
tion Code of the Czech Republic, the appropriate directive of the
European Union (2010/63/EC) and NIH guidelines. Male adult
Wistar rats (12–14 weeks, weighing 250–350 g) were obtained from
the Institute’s accredited breeding colony. Animals were housed in
pairs in 30 cm× 30 cm× 40 cm transparent plastic cages in a labo-
ratory air-conditioned animal facility with a constant temperature
(21°C) and 12:12 light/dark cycle with lights on at 7:00. Water and
food were available ad libitum throughout the experiments. In
all experiments, eight animals were used per group. Seventy-two
animals were used in total.
DRUGS
Psilocin 1 and 4 mg/kg (synthesized at Pharmaceutical Faculty of
Charles University in Prague, the structure was confirmed by mass
spectroscopy and nuclear magnetic resonance techniques) was dis-
solved in saline (0.9% NaCl) acidified with 10µl of glacial acetic
acid. All injections were administered subcutaneously (s.c.) at a
volume of 2 ml/kg. Fresh solutions were prepared every day, stored
at 4°C and were protected from light.
EXPERIMENTAL APPARATUSES AND BEHAVIORAL PROCEDURES
Carousel maze
The Carousel maze apparatus was described in detail in our pre-
vious study (Stuchlik et al., 2007, 2013). Briefly, it consisted of a
smooth metallic circular arena (82 cm in diameter), enclosed with
a 30-cm high transparent Plexiglas wall and elevated 1 m above
the floor of a 4 m× 5 m room. The room contained an abun-
dance of extra-maze landmarks. The rats were initially placed in
the arena rotating at 1 rpm in a place directly opposite to the shock
sector. Animals had to avoid a directly imperceptible 60° sector,
defined in the North of the four arbitrary cardinal compass direc-
tions. The sector was identifiable solely by its relationships to distal
room cues. A latex harness was attached between the shoulders of
the rats, which carried an infrared light-emitting diode (LED). A
computer-based tracking system (iTrack; Biosignal Group, USA)
was located in an adjacent room. The tracking system recorded the
rat’s position every 40 ms. Position time series were stored for off-
line analyses (Track Analysis; Biosignal Group, USA). Whenever
the rat entered the to-be-avoided sector for more than 0.5 s, the
tracking system delivered a shock and counted an entrance. If the
rat did not leave the sector, additional shocks were given every 1.4 s,
but no more entrances were counted until the rat left the sector
for more than 0.5 s. Mild shocks (50 Hz, 0.5 s, 0.4–0.7 mA) were
administered from a computer-driven shock generator through
the implanted low-impedance hypodermic needle implanted on
the rats’ backs and through the contact between the rats’ kera-
tinized paws and the grounded arena floor. Since the voltage drop
is highest at the contact between rats’ paws and the floor, the rats
“feel” the shock most likely in their feet. We avoided using a grid
because in the Carousel maze it is necessary to allow accumulation
of scent marks on the floor in order to generate a conflict between
the arena and the room frames. The exact shock current, ranging
between 0.4 and 0.7 mA, was adjusted for each rat to elicit a rapid
escape response but not freezing. Rats were trained 4 days, 30 min
after psilocin injection in four acquisition sessions of Carousel
maze. On the fifth day, animals were tested without the presence
of the drug (after-session). While the first four sessions evaluate the
learning capacity, the last session would correspond to the short-
term memory. The sector position was kept constant on the North
compass direction throughout the training. The interval between
sessions was 24 h. Eight animals were used in each group (24 rats
in total).
Morris water maze
The MWM consisted of a blue-painted metallic circular tank
(180 cm in diameter, 50 cm high) filled with water (20°C, 40 cm
deep). A small, transparent Plexiglas escape platform (10 cm in
diameter) was placed in the center of an arbitrarily defined North-
east (NE) quadrant of the pool and submerged 1.5 cm below the
water surface. Rats were released facing the wall from the four
cardinal compass directions (N, W, S, and E) in a quasi-random
order. A trial stopped when the rat found the escape platform and
climbed upon it. If the rat failed to find the escape platform in
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60 s, the trial was stopped (recording latency of 60 s), and the rat
was gently guided to the platform by the experimenter. The escape
latency was recorded by the experimenter using a stopwatch. The
rat was allowed to stay on the platform for 10 s and then it was
placed to a waiting cage. One daily session consisted of eight swims
(trials).
In the reinforced retrieval experiment four acquisition sessions
(each consisting of eight swims) were conducted without the drug.
On Day 5, psilocin was applied s.c. (1 or 4 mg/kg) 30 min prior to
testing and the rats were released again for eight swims under
the influence of the drug with the platform present in the same
location of the pool (reinforced retrieval). Reinforced retrieval
(actually re-acquisition) was chosen over a classical probe trial
to also investigate re-acquisition under the drug. Five days later,
drug-free animals underwent another re-acquisition with the plat-
form present. Eight animals were used in each group (24 rats in
total).
The experiment dedicated to testing the effect of psilocin on
memory consolidation consisted of an initial 16 trials in the first
session (Day 1) followed by psilocin injection immediately after
the last swim at doses of 1 or 4 mg/kg, s.c. On the subsequent day
(Day 2), the animals were released again for eight trials (swims)
without any injections and the platform was again present in the
same position (NE). Eight animals were used in each group (24
rats in total).
DATA ANALYSIS AND STATISTICS
The total distance traveled in a session (measured in the arena
frame) reflected active locomotor activity without the contri-
bution of the passive arena rotation. The distance was mea-
sured by the off-line tracking system by summing linear dis-
tances of points recorded each 1 s (the sampling frequency was
40 Hz). This sampling eliminated non-locomotor movements
of the rat such as shivering. The number of entrances into
the to-be-avoided sector (number of errors) measured the effi-
ciency of avoidance in the Carousel maze. Another measure
of the spatial performance within the session was the maxi-
mum time between the two entrances in a session (maximum
time avoided). Results were analyzed using a two-way ANOVA
(Groups× Sessions) with repeated measures on sessions, and
Tukey’s HSD test was used when appropriate. Significance was
accepted at P < 0.05.
In the MWM, we recorded the latency to find the platform
as a measure of spatial memory (Morris, 1981; Stuchlik et al.,
2007) and analyzed it with a two-way ANOVA (Groups× Sessions)
with repeated measures on sessions. Tukey’s HSD test was used as
post hoc when appropriate. We were not able to track the trajecto-
ries of the animals in this MWM experiment (however, locomotion
was assessed in the Carousel maze; see the previous paragraph).
RESULTS
EFFECT OF PSILOCIN ON THE ACQUISITION OF THE CAROUSEL MAZE
The animals did not exhibit any signs of stress or excessive
discomfort during or after the drug injections. All data are
summarized in Figure 1. First, we analyzed the locomotor
activity, which was different between 1 mg/kg of psilocin, 4 mg/kg
of psilocin, and the control group. A two-way ANOVA with
FIGURE 1 |The effect of psilocin on locomotor activity, number of
entrances, and maximum time avoided in the Carousel maze. Psilocin
impaired spatial memory acquisition (higher number of entrances) at both
doses. #P < 0.05, psilocin 1 group (1 mg/kg, s.c.) compared to the control
group on the same day. *P <0.05, psilocin 4 group (4 mg/kg, s.c.)
compared to the control group on the same day.
repeated measures on sessions revealed a significant main effect of
group [F(2, 22)= 8.51; P < 0.001] and sessions [F(4, 88)= 44.4;
P < 0.0001] and interaction between the two factors [F(8,
88)= 3.47; P < 0.001]. The locomotor activity of the control
group increased during the first three sessions and then stabilized
to a constant level. There was no significant difference between
the control group and the group treated with 1 mg/kg of psilocin
(P > 0.05) during all five sessions. The group treated with 4 mg/kg
of psilocin significantly differed from the control group only
during the first three sessions (P < 0.05). These results show that
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a dose of 4 mg/kg of psilocin induced a decrease in locomotor
activity but the locomotion of this group still increased with the
training. This increasing trend persisted even in session 5 (the
day without the application of psilocin), the locomotor activity
was significantly higher in session 5 than in session 4 (P < 0.01).
These results show that the dose of 4 mg/kg of psilocin impaired
locomotor activity in the Carousel maze, whilst the dose of 1 mg/kg
did not affect it.
The analysis of the number of entrances into the shock
sector revealed differences between the studied groups. The
two-way ANOVA showed a significant main effect of groups
[F(2, 20)= 6.86; P < 0.01] and a main effect of sessions [F(4,
80)= 20.64; P < 0.0001]. There was also an effect of the inter-
action between these two factors [F(8, 80)= 3.95; P < 0.001]. A
post hoc analysis of the factor of sessions showed that in the con-
trol group performance was better in sessions 3–5 compared to
the first session (P < 0.05). The group treated with the low dose of
psilocin (1 mg/kg) showed significant impairment in solving the
Carousel maze task in sessions 3 and 4. The group treated with the
higher dose of psilocin 4 mg/kg showed significant impairment in
solving the Carousel maze in sessions 3 through 5. The higher dose
of psilocin 4 mg/kg blocked the learning processes even in session
5 when the rats received saline instead of psilocin, although state-
dependent learning might explain the impairment on the last day
of training.
The maximum time avoided is generally strongly inversely cor-
related with the number of errors. Accordingly, analysis of this
parameter also revealed differences between the studied groups.
The two-way ANOVA showed a significant main effect of groups
[F(2, 20)= 15.7; P < 0.0001] and a main effect of sessions [F(4,
80)= 12.5; P < 0.0001]. There was also an effect of the interaction
between these two factors [F(8, 80)= 3.38; P < 0.01]. A post hoc
comparison between the groups revealed that the control group
exhibited a higher maximum time avoided in session 4 than the
two groups treated with psilocin (1 and 4 mg/kg). There were no
significant differences between the group treated with psilocin 1
and 4 mg/kg.
EFFECT OF PSILOCIN ON MEMORY RETRIEVAL IN THE MWM
We analyzed the behavioral parameter related to performance in
the MWM, escape latency (Figure 2). Animals from all groups
were pre-trained in the reference memory version of the MWM
for 4 days without drug injections; the performance was similar
across all of the groups [no significant effect between groups on
Day 1–4 F(2, 20)= 2.1; P = 0.14]. There was a significant effect
of days on all measures [F(2, 20)= 7.77; P < 0.0031]. On Day 5,
memory retrieval was tested under the influence of psilocin (1
or 4 mg/kg, s.c). There was significant effect of days and sessions
[F(2, 20)= 4.88; P < 0.01; F(7, 140)= 4.7; P < 0.0001]. Post hoc
tests indicated that the retrieval was impaired in the group treated
with a 4-mg/kg dose (P < 0.01). We found an effect of groups and
sessions [F(2, 20)= 5.91; P < 0.01; F(7, 140)= 6.46; P < 0.0001]
5 days after the psilocin treatment. A control retrieval experiment
was pursued without injections; surprisingly, the group with the
previously administered high dose of psilocin was impaired again
(P < 0.01).
FIGURE 2 | Psilocin treatment (4mg/kg) disrupted memory retrieval in
the MWM after 4days of pre-training and also impaired memory
retrieval 5 days later (Day 10) without the presence of the drug.
*P <0.05, compared to the control group on the same day.
FIGURE 3 | Psilocin injected after training on Day 1 had no effect on
memory consolidation at both doses (1 or 4mg/kg) in the MWM.
EFFECT OF PSILOCIN ON MEMORY CONSOLIDATION IN THE MWM
The animals were trained for 16 trials without drug injection on
the first day (Day 1); subsequently, psilocin was injected (1 or
4 mg/kg) to investigate its effect of memory consolidation. On the
next (Day 2), the animals were re-tested in the MWM with the
same platform position. Psilocin did not affect the consolidation
in the MWM. We found no effect of groups and sessions [F(2,
42)= 1.110; P = 0.3390; F(1, 42)= 1.163; P = 0.2870]. Figure 3
shows slightly better cognitive performance than on Day 1, but no
significant between-group differences.
DISCUSSION
Our findings indicate that psilocin affects learning and mem-
ory acquisition necessary for spatial navigation and that it also
has a disruptive effect on memory retrieval in MWM. Previous
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reports on the effects of psilocin/psilocybin on cognition in ani-
mals are very sparse, use different paradigms and did not bring
uniform results, which make them difficult to compare. One study
in rats reported impaired acquisition of a conditioned avoidance
response (Sugrue, 1969) while another one in mice did not find
any effect on the acquisition of an escape avoidance conditioning
task (Collins et al., 1966). However, both studies were conducted
with very high doses of psilocin/psilocybin. Furthermore, oppos-
ing effects of low psilocin doses on memory consolidation were
found in two different mice strains when psilocin was injected
immediately after each training session in a light–dark discrim-
ination task (Castellano, 1978). On the other hand, most of the
studies with other hallucinogens congruently found a disruption
of cognitive performance. Similar findings to ours were shown
for 2,5-dimethoxy-4-iodoamphetamine (DOI) in a special water
maze, where this compound worsened the performance during
acute intoxication as well as when subsequently tested without the
influence of the drug (Kant et al., 1998). Early studies with LSD
and mescaline congruently found disruption of spatial naviga-
tion, exploration, and discrimination within different frameworks
in T-maze/Y-maze (Castellano, 1971; Davies and Redfern, 1973;
Molinengo et al., 1986; Koupilova et al., 1989, 1999). LSD and
other hallucinogens also induced errors in swimming through
an underwater maze and increased starting latency of swimming
through the maze (Uyeno, 1969, 1986). Recently, the use of a
translational touch-screen based approach also showed alterations
in visuo-spatial learning after acute LSD treatment in rats (Tal-
pos et al., 2014). Finally, chronic mescaline treatment completely
blocked the ability to switch between learned trials during operant
conditioning (food reinforcement) (Fundaro et al., 1986).
There are two main aspects that have a crucial role in psilocin
induced changes. Firstly, psilocybin, like other hallucinogens, had
an inhibitory effect on locomotor and exploratory activity with
the higher dose used (Collins et al., 1966; Halberstadt et al., 2011;
Palenicek et al., 2012, 2013). However, we believe that the main
effect of locomotor inhibition can be excluded, since the lower
psilocin dose in the Carousel maze did not significantly differ from
the controls during any of the sessions even though it induced the
deficit in this task. Furthermore, the higher dose during session
4, when the animals showed peak performance, did not induce
any significant locomotor inhibition. The psilocin-treated ani-
mals also showed a trend toward an increase in their locomotion
within every session similarly to the control group, suggesting
either developing tolerance to the drug or task sensitization. On
the other hand, such an increase might also be attributable to
the gradual acquisition of an avoidance strategy, which requires a
highly coordinated spatiotemporal locomotion pattern in order to
avoid a sector.
Secondly, since active avoidance in the Carousel maze as well
as the MWM are spatial tasks requiring extra-maze cue orienta-
tion for successful acquisition, altered spatiotemporal perception
(hallucinatory effects) can definitely contribute/underlie these
changes. Unlike human studies on psilocybin (for a review, see
Tyls et al., 2013); unfortunately, we are unable to directly con-
firm hallucinatory effects in rats in our setting. However, previous
studies in rodents found an attenuation of time perception after
hallucinogens (Hanks and González-Maeso, 2013) and studies
in primates also support hallucinogenic effects in these species
(Uyeno, 1969; Fantegrossi et al., 2004). Therefore, we might expect
temporal and visual perceptual alterations to be present also in
our setting. Indeed, it is well known that psilocin induces atten-
tion distraction (Hasler et al., 2004; Carter et al., 2005), which
can also underlie the learning deficits. Interestingly, learning in
the Carousal maze was also disrupted in the after-session, with no
exposition to psilocin, indicating that psilocin blocked the learn-
ing process until the last session. Also, the higher dose of psilocin
disrupted memory retrieval in the MWM, an effect that persisted
for another 5 days. In other words, the rats that received psilocin
during the retrieval trial did not improve their performance dur-
ing this task, contrary to the control group, suggesting that not
only retrieval but also re-acquisition was corrupted. This supports
the idea that psilocin also had amnestic effects.
It is well known from the literature that psilocin effects are
mainly mediated through 5-HT2A/C and 5-HT1A receptors (Tyls
et al., 2013). These receptors are widely distributed in the neo-
cortex, basal ganglia, limbic system, and hippocampus and in the
case of 5-HT1A also in rapheal nuclei (Barnes and Sharp, 1999).
All of these areas are known to be involved in cognitive processes
and memory. It is well known that 5-HT2A/C receptors in particu-
lar are rapidly downregulated/desensitized after stimulation (Roth
et al., 1990, 1995, 1998). This can explain the loss of the locomotor
inhibitory effect observed in the Carousel maze. Since systemic
administration of 5-HT2A receptor antagonists induces cognitive
deficit in rats (Ma and Yu, 1993; Fedotova and Ordyan, 2010)
the down-regulation/desensitization of 5-HT2A/C receptors after
repeated administration of psilocin might also yield some of the
effects observed in our setting. It is of interest that stimulation of
5-HT1A and 5-HT1B receptors is also known to impair acquisition
of spatial memory tasks (Buhot et al., 1995; Herremans et al., 1995;
Koenig et al., 2008). Nevertheless, further experiments are needed
to explain the receptor mechanisms underlying these changes.
In conclusion, our study demonstrated that 5-HT2A/C and 5-
HT1A agonist psilocin impaired spatial learning in the Carousel
maze and it also had an amnestic effect in the MWM. On the
other hand, it had no effect on memory consolidation.
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